Insider · CIK 0001721541
Paul Hukkanen
officer
Files at SCHL (SCHOLASTIC CORP). First filing Mar 27, 2026, latest Mar 27, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $394k sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -594 | $35.30 | $21k | 15,349 | 7 d ago |
| Sep 29, 2026 | SCHL SCHOLASTIC CORP | AGrant or award Common Stock | +3,467 | $34.61 | $120k | 15,943 | 11 d ago |
| Sep 28, 2026 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -434 | $32.74 | $14k | 12,476 | 13 d ago |
| Sep 23, 2026 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -710 | $35.09 | $25k | 12,910 | 17 d ago |
| Mar 25, 2026 | SCHL SCHOLASTIC CORP | MOption exercise Common Stock | +10,000 | $21.03 | $210k | 23,620 | Mar 27, 2026 |
| Mar 25, 2026 | SCHL SCHOLASTIC CORP | SOpen-market sale Common Stock | -10,000 | $39.40 | $394k | 13,620 | Mar 27, 2026 |
| Mar 25, 2026 | SCHL SCHOLASTIC CORP | MOption exercise Employee Stock Options (right to buy)derivative | -10,000 | $0.00 | $0 | 0 | Mar 27, 2026 |
| Oct 1, 2025 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -399 | $27.69 | $11k | 13,620 | Oct 2, 2025 |
| Sep 26, 2025 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -291 | $26.80 | $7,799 | 14,019 | Sep 30, 2025 |
| Sep 23, 2025 | SCHL SCHOLASTIC CORP | AGrant or award Common Stock | +4,654 | $25.78 | $120k | 14,310 | Sep 25, 2025 |
| Sep 22, 2025 | SCHL SCHOLASTIC CORP | FTax withholding Common Stock | -255 | $25.01 | $6,378 | 9,656 | Sep 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.